Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jun 12, 2025 · Filed Jun 13, 2025
The CEO of Aim Immunotech paid $896 out of pocket for Aim Immunotech shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$896
Shares × reported transaction price
<$25K
+0.3%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 2 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 9 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals less than 1% of the CEO's reported total pay for fiscal 2024 ($1.09M)
Purchase value ÷ the CEO's total from the Summary Compensation Table, as tagged in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-09-30. The proxy names Thomas K. Equels as CEO for that year. A size comparison, not a judgement
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −8.4% | +1.6% | −9.9% |
| 30 days | −14.7% | +5.1% | −19.8% |
| 90 days | −74.9% | +10.6% | −85.5% |
| 180 days | −87.0% | +13.9% | −100.9% |
| 365 days | −96.1% | +24.0% | −120.1% |
Past results only. Not a forecast.
Insider buying
Traded Jun 13, 2025 · filed 3 days later
The CEO of Aim Immunotech paid $824 out of pocket for Aim Immunotech shares.
Insider buying
Traded Apr 11, 2025 · filed 12 days later
An Aim Immunotech director paid $50K out of pocket for Aim Immunotech shares. 3 other people at Aim Immunotech bought some too, in the same month. Shares held went up 196850% with this purchase.
Insider buying
Traded Apr 11, 2025 · filed 12 days later
The CEO of Aim Immunotech paid $50K out of pocket for Aim Immunotech shares. 3 other people at Aim Immunotech bought some too, in the same month. Shares held went up 104% with this purchase.
Thomas K Equels, CEO & President's past purchases, 90 days after disclosure: 5 buys, median −40.0 pts vs S&P 500, beat it 0 of 5 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
